Amina Haddad

Clinician

ProfileSettings

Appearance

Amina HaddadClinician
ProfileSettings

Appearance

Tirzepatide dosing in renal impairment

Today’s digest

Tirzepatide dosing in renal impairment

Cite
  • A sample paper: it is fictional, so don’t cite it. The formats are real.
  • There is no DOI in ReadSearch’s record for this paper, so the citation links to the page instead.

APA 7

Whitfield, R. (2026). Tirzepatide dosing in renal impairment. NEJM.

MLA 9

Whitfield, R. “Tirzepatide dosing in renal impairment.” NEJM, 2026.

Chicago

Whitfield, R. 2026. “Tirzepatide dosing in renal impairment.” NEJM.

Harvard

Whitfield, R. (2026) ‘Tirzepatide dosing in renal impairment’, NEJM.

Vancouver

Whitfield R. Tirzepatide dosing in renal impairment. NEJM. 2026.

BibTeX

@article{whitfield2026tirzepatide,
  title = {{Tirzepatide dosing in renal impairment}},
  author = {Whitfield, R.},
  year = {2026},
  journal = {NEJM}
}

RIS

TY  - JOUR
TI  - Tirzepatide dosing in renal impairment
AU  - Whitfield, R.
PY  - 2026
JO  - NEJM
ER  - 
Endocrinology & Metabolism
Tirzepatide dosing in renal impairment
Whitfield R
ReadSearch
NEJM
2026
Read the full paper
Tirzepatide dosing in renal impairment
NEJM · 2026
ReadSearch
NEJM
2026

Tirzepatide dosing in renal impairment — ReadSearch